A rare epilepsy of the first three years of life in which an otherwise normal baby begins to have brief myoclonic jerks: a sudden nod of the head, a shrug, the arms flinging upward and outward, over in a second or less. Development up to that point has been normal, the head is a normal size, the examination is normal, and the only abnormality is a burst of generalized spike-wave on the electroencephalogram locked to each jerk. The seizures usually respond to valproate and usually stop, which is why the syndrome carried the word "benign" for forty years. That word has since been removed, and for a reason that is the whole interest of the entry: seizure freedom and good outcome turn out not to be the same thing here. About a third of children followed long enough have cognitive difficulty, in a syndrome named for not causing any. A subset of infants have jerks provoked reliably by a sudden touch or noise rather than occurring spontaneously, and whether those children have the same disease is still argued.
Ask a research question about Myoclonic Epilepsy in Infancy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Myoclonic Epilepsy in Infancy:
name: Myoclonic Epilepsy in Infancy
creation_date: "2026-08-05T00:00:00Z"
category: Complex
description: >-
A rare epilepsy of the first three years of life in which an otherwise normal
baby begins to have brief myoclonic jerks: a sudden nod of the head, a shrug,
the arms flinging upward and outward, over in a second or less. Development up
to that point has been normal, the head is a normal size, the examination is
normal, and the only abnormality is a burst of generalized spike-wave on the
electroencephalogram locked to each jerk. The seizures usually respond to
valproate and usually stop, which is why the syndrome carried the word
"benign" for forty years. That word has since been removed, and for a reason
that is the whole interest of the entry: seizure freedom and good outcome turn
out not to be the same thing here. About a third of children followed long
enough have cognitive difficulty, in a syndrome named for not causing any. A
subset of infants have jerks provoked reliably by a sudden touch or noise
rather than occurring spontaneously, and whether those children have the same
disease is still argued.
parents:
- Epilepsy
- Neurological Disease
synonyms:
- MEI
- benign myoclonic epilepsy of infancy
- benign myoclonic epilepsy in infancy
- BMEI
- myoclonic epilepsy of infancy
classifications:
harrisons_chapter:
- classification_value: NEUROLOGIC
notes: >-
An ILAE-recognized self-limited epilepsy syndrome with onset in infancy,
diagnosed and managed neurologically.
disease_term:
preferred_term: myoclonic epilepsy in infancy
term:
id: MONDO:0100566
label: myoclonic epilepsy in infancy
mappings:
mondo_mappings:
- term:
id: MONDO:0100566
label: myoclonic epilepsy in infancy
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
MONDO:0100566 is the myoclonic epilepsy in infancy concept, carrying MEI
and the historical "benign myoclonic epilepsy of infancy" as exact
synonyms and cross-referencing Orphanet:86909.
references:
- reference: PMID:16904290
title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and reflex
myoclonic epilepsy in infancy: a literature review and six new cases.
- reference: PMID:23770486
title: "Reflex myoclonic epilepsy in infancy: a critical review."
- reference: PMID:35503712
title: >-
ILAE classification and definition of epilepsy syndromes with onset in
neonates and infants: Position statement by the ILAE Task Force on Nosology
and Definitions.
notes: >-
Naming, and why it changed. The syndrome was described by Dravet and Bureau in
1981 as "the benign myoclonic epilepsy of infancy" and carried that name for
four decades. The 2022 ILAE nosology renamed it myoclonic epilepsy in infancy,
dropping "benign" as part of a general removal of that word from the epilepsy
syndromes. In most cases the removal was a matter of principle, since the word
reassures families about a disease that is still an epilepsy. Here it is
substantive: the seizures really do remit, but a substantial minority of
children have lasting cognitive difficulty, so the old name was making a claim
the data do not support. That tension is curated as a discussion rather than
settled in prose.
Scope. This entry models the syndrome as a whole and treats reflex myoclonic
epilepsy in infancy as a subset within it, because that is how the primary
literature is organized, while recording explicitly that this inclusion is
disputed. If the reflex variant is later separated as its own entity it should
get its own entry rather than a subtype block here, and the discussion says so.
What is deliberately absent. There is no genetic section. Family history of
epilepsy or febrile seizures is common and the literature reads the clinical
heterogeneity as pointing toward several underlying genetic mechanisms, but no
gene has been established for this syndrome, and no candidate is named in the
sources cited here. Importing genes from adjacent infantile myoclonic
epilepsies would fabricate content; the absence is recorded as a knowledge gap
instead.
Sourcing note. Drafted from the primary literature, then cross-checked against
a deep-research report generated with the falcon provider (Edison Scientific),
committed as research/Myoclonic_Epilepsy_in_Infancy-deep-research-falcon.md.
It contributed no snippets; every quotation here is verified against its own
fetched cache. It converged on the substance of this entry and added four
things worth recording.
Two are naming traps that a future curator should not walk into. First, Dravet
syndrome was historically called severe myoclonic epilepsy in infancy, so the
two syndromes have almost the same old name and opposite prognoses; that is why
Dravet is carried here as the leading differential. Second, familial infantile
myoclonic epilepsy is a separately indexed genetic entity associated with genes
including TBC1D24, SCN8A, CPLX1 and KIF5A, and it is not this syndrome. The
report is explicit that gene-associated cases described as myoclonic epilepsy
of infancy should be read as possible phenocopies rather than as evidence that
this syndrome is monogenic, and that SCN1A, SLC2A1 and YWHAG should not be
asserted as established causes. That is the same conclusion the genetic
knowledge gap below reaches independently, and it is the reason no genetic
section exists here.
Third, the report notes that Open Targets holds this entity as MONDO:0100566
with no established disease-target association, which is consistent with the
absence of a molecular handle.
Fourth, the report described roughly a tenth of children later developing
another epilepsy, most commonly juvenile myoclonic epilepsy. That gap has since
been closed with a citable source: PMID:21752671 states that a few patients
later had other epilepsy types, mainly idiopathic generalized epilepsies, and
reports the first case that went on to childhood absence epilepsy. It is now
curated as a progression phase and in the evolution discussion. The specific
one-in-ten figure and the juvenile-myoclonic-epilepsy attribution are still not
asserted here, because that source does not give them.
Module conformance note. Two nodes conform to
epilepsy_excitation_inhibition_imbalance, at the hyperexcitability and
recurrent-seizure nodes. The module makes no claim about the age restriction or
about the myoclonic semiology, which are this entry's specific contributions.
inheritance:
- name: Presumed genetic and heterogeneous, no established locus
description: >-
No mode of inheritance is established and no locus is known. The literature
infers a genetic contribution from the clinical picture rather than from
mapping: the syndrome is clinically heterogeneous enough that reviewers
have suggested several distinct genetic mechanisms may produce the same
presentation. No inheritance_term is bound, because binding one would
assert a mode of transmission that has not been demonstrated.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The clinical heterogeneity within this syndrome suggests that there may
be a variety of genetic mechanisms that underlie the presentation.
explanation: >-
States the inference exactly as the field makes it, from clinical
heterogeneity to presumed genetic heterogeneity, without naming a gene
or a mode of inheritance.
pathophysiology:
- name: Age-Restricted Generalized Cortical Hyperexcitability of Infancy
biological_scale: TISSUE
conforms_to: "epilepsy_excitation_inhibition_imbalance#Neuronal Hyperexcitability and Hypersynchrony"
description: >-
The substrate is a transient, presumed genetic tendency of the infant brain
to generate generalized epileptic discharge, appearing in the first three
years of life and generally disappearing after it. Nothing is known about
it at the molecular level, and this entry does not pretend otherwise: the
node carries cellular annotation and no gene. What justifies calling it
generalized rather than focal is that the discharge is generalized on the
recording and the jerk it produces is bilateral. What justifies calling it
age-restricted is that both the onset and the remission are tied to a
developmental window rather than to any event.
cell_types:
- preferred_term: cortical neuron
term:
id: CL:0000540
label: neuron
biological_processes:
- preferred_term: neuronal action potential
term:
id: GO:0019228
label: neuronal action potential
modifier: INCREASED
downstream:
- target: Generalized Epileptiform Discharge Time-Locked to the Jerk
- target: Reflex Sensitivity to Tactile and Acoustic Stimuli in a Subset
- target: Age-Dependent Remission of the Seizure Disorder
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy, classified among the generalised
idiopathic epilepsies, is characterised by the occurrence of myoclonic
seizures in the first three years of life in otherwise normal infants.
explanation: >-
Establishes the three components this node asserts: a generalized
rather than focal mechanism, a restricted age window, and an otherwise
normal infant, which is what makes the substrate a functional
excitability state rather than a lesion.
- name: Generalized Epileptiform Discharge Time-Locked to the Jerk
biological_scale: TISSUE
description: >-
The electrographic event: a brief burst of generalized spike-wave or
polyspike-wave, coinciding with the myoclonic jerk closely enough that the
two can be shown to be one event on combined recording. This time-locking
is what makes the jerk a seizure rather than a movement disorder, and it is
the single most useful discriminator from the non-epileptic myoclonias of
infancy that otherwise look identical at the cotside.
cell_types:
- preferred_term: cortical neuron
term:
id: CL:0000540
label: neuron
downstream:
- target: Brief Generalized Myoclonic Seizures
evidence:
- reference: PMID:21752671
reference_title: >-
Benign myoclonic epilepsy in infancy followed by childhood absence
epilepsy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The ictal video-EEG and polygraphic recording revealed generalized
discharge of spike-wave (SW) lasting 1-2s associated with isolated
bilateral synchronous jerk involving mainly the upper limbs controlled
by valproic acid (VPA).
explanation: >-
Direct polygraphic evidence for every element of this node: the
discharge is generalized spike-wave, it is brief, and it is recorded in
association with the bilateral jerk rather than merely alongside it,
which is what time-locking means here.
- name: Reflex Sensitivity to Tactile and Acoustic Stimuli in a Subset
biological_scale: ORGANISM
description: >-
In a subset of infants the jerks are not spontaneous but are elicited
reliably by a sudden unexpected touch or noise. Whether these children have
a variant of the same syndrome or a separate one is genuinely disputed, and
this node exists to make the disputed branch explicit in the graph rather
than leaving it in prose. What can be said from the evidence is that the
reflex group is developmentally normal in every reported case, which is a
real difference from the syndrome as a whole and is the strongest argument
for separating them.
downstream:
- target: Brief Generalized Myoclonic Seizures
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Some authors have described cases of myoclonic seizures as a reflex
response to sudden unexpected tactile or acoustic stimuli and this
clinical entity has been proposed as a separate nosographic syndrome,
referred to as "reflex myoclonic epilepsy in infancy" (RMEI).
explanation: >-
Names the trigger modalities and records that the entity has been
proposed as separate, which is precisely the disputed status this node
encodes.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The cognitive outcome in reflex myoclonic epilepsy of infancy is normal
in all reported cases.
explanation: >-
The outcome difference that distinguishes the reflex subset from the
syndrome as a whole, and the main empirical argument for treating it as
a separate entity.
- name: Brief Generalized Myoclonic Seizures
biological_scale: ORGANISM
conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
description: >-
The clinical seizure: a sudden brief bilateral jerk, usually of the head
and upper limbs, lasting a second or less, often in clusters. Consciousness
is not obviously impaired, which is one reason the events are frequently
dismissed at first as startles or colic. In this syndrome the myoclonic
seizure is the only seizure type; the appearance of other seizure types is
a reason to doubt the diagnosis.
downstream:
- target: Age-Dependent Remission of the Seizure Disorder
- target: Persisting Cognitive and Behavioural Difficulty in a Minority
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy, classified among the generalised
idiopathic epilepsies, is characterised by the occurrence of myoclonic
seizures in the first three years of life in otherwise normal infants.
explanation: >-
Establishes the myoclonic seizure as the characteristic and defining
seizure type of the syndrome.
- name: Age-Dependent Remission of the Seizure Disorder
biological_scale: ORGANISM
description: >-
The seizures stop. Long-term seizure freedom is the expected outcome and is
the property that places the syndrome among the self-limited rather than
the encephalopathic infantile epilepsies. Valproate is the most effective
treatment, which is a statement about seizure control rather than about
whether treatment alters the natural history, a question the literature
does not answer.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Prognosis in respect of long term seizure freedom is good with sodium
valproate being the most effective medication.
explanation: >-
States both the favourable seizure outcome and the drug it is achieved
with, in one sentence.
- reference: PMID:35503712
reference_title: >-
ILAE classification and definition of epilepsy syndromes with onset in
neonates and infants: Position statement by the ILAE Task Force on
Nosology and Definitions.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Syndromes are separated into self-limited syndromes, where there is
likely to be spontaneous remission and developmental and epileptic
encephalopathies, diseases where there is developmental impairment
related to both the underlying etiology independent of epileptiform
activity and the epileptic encephalopathy.
explanation: >-
Defines the self-limited category this syndrome belongs to, and by
contrast the encephalopathy category it does not, which is the
classificatory meaning of this node.
- name: Persisting Cognitive and Behavioural Difficulty in a Minority
biological_scale: ORGANISM
description: >-
The reason the syndrome is no longer called benign. Roughly a third of
children with long-term follow-up have cognitive problems, despite seizures
that remitted and an infancy that looked normal before onset. Whether this
reflects the seizures, the underlying substrate that produced them, or the
medication used to stop them is not established, and the entry does not
choose. The practical consequence is stated plainly in the source: the word
benign may be applied to the seizures but must be used cautiously when
counselling a family about their child's development.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
However, the cognitive outcome is much less certain with cognitive
problems present in one-third of children who have long term follow up.
explanation: >-
The quantitative basis for this node: one third of children with long
follow-up, in a syndrome whose name asserted the opposite.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The term benign may be appropriately used to describe the myoclonic
seizures but must be used cautiously when counselling families about
cognitive outcome.
explanation: >-
The authors' own separation of the seizure prognosis from the
developmental prognosis, which is the distinction this node exists to
make.
phenotypes:
- category: Neurological
name: Generalized Myoclonic Seizures
description: >-
Brief bilateral jerks of head and upper limbs, lasting a second or less,
often in clusters, and the only seizure type of the syndrome.
phenotype_term:
preferred_term: Generalized myoclonic seizure
term:
id: HP:0002123
label: Generalized myoclonic seizure
frequency: VERY_FREQUENT
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy, classified among the generalised
idiopathic epilepsies, is characterised by the occurrence of myoclonic
seizures in the first three years of life in otherwise normal infants.
explanation: >-
The myoclonic seizure is the characterising feature of the syndrome,
which supports a very frequent band by definition of the diagnosis.
- category: Neurological
name: Reflex Myoclonic Seizures
description: >-
In a subset, jerks elicited reliably by sudden unexpected tactile or
acoustic stimulation rather than occurring spontaneously.
phenotype_term:
preferred_term: Reflex seizure
term:
id: HP:0020207
label: Reflex seizure
frequency: OCCASIONAL
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Some authors have described cases of myoclonic seizures as a reflex
response to sudden unexpected tactile or acoustic stimuli and this
clinical entity has been proposed as a separate nosographic syndrome,
referred to as "reflex myoclonic epilepsy in infancy" (RMEI).
explanation: >-
Documents the reflex presentation and its trigger modalities.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This includes 23 infants with reflex myoclonic epilepsy whose inclusion
in the wider syndrome remains debatable.
explanation: >-
Gives the size of the reflex subset relative to the just-over-100 cases
reported for the whole syndrome, which is the basis for the occasional
band.
- category: Neurological
name: EEG with Generalized Epileptiform Discharges
description: >-
Generalized spike-wave or polyspike-wave bursts, time-locked to the
myoclonic jerk, against an otherwise normal background.
phenotype_term:
preferred_term: EEG with generalized epileptiform discharges
term:
id: HP:0011198
label: EEG with generalized epileptiform discharges
evidence:
- reference: PMID:21752671
reference_title: >-
Benign myoclonic epilepsy in infancy followed by childhood absence
epilepsy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The ictal video-EEG and polygraphic recording revealed generalized
discharge of spike-wave (SW) lasting 1-2s associated with isolated
bilateral synchronous jerk involving mainly the upper limbs controlled
by valproic acid (VPA).
explanation: >-
States the discharge morphology and its association with the jerk. No
frequency band is assigned, because this is a single polygraphically
documented case and no cited source quantifies how often the finding is
present across the syndrome.
- category: Neurological
name: Cognitive Impairment
description: >-
Cognitive difficulty in a substantial minority of children followed long
term, despite remission of the seizures. The source says cognitive
problems, a category that spans learning difficulty and attention problems
as well as intellectual disability, so the term is deliberately the
unqualified one: assigning a severity grade would assert something the
literature does not.
phenotype_term:
preferred_term: Cognitive impairment
term:
id: HP:0100543
label: Cognitive impairment
frequency: FREQUENT
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
However, the cognitive outcome is much less certain with cognitive
problems present in one-third of children who have long term follow up.
explanation: >-
One third of children with long-term follow-up is 33 percent, which
falls in the FREQUENT band rather than OCCASIONAL. The band and the
term are both taken directly from this sentence: it says cognitive
problems, and it says one-third.
prevalence:
- population: Infants with epilepsy
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
Just over 100 cases had been reported in the four decades between the first
syndromic description in 1981 and this review, of which 23 were the
disputed reflex subset. No population-based rate exists. The measure_type is
CASES_IN_LITERATURE because a cumulative published case count is what the
literature offers, and the prevalence_class is the qualitative ULTRA_RARE
tier because a case count cannot be converted into a rate.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy is a rare syndrome with just over
100 cases reported since the first syndromic description by Dravet and
Bureau
explanation: >-
Gives the cumulative published case count and dates it from the original
syndromic description.
progression:
- phase: Onset of myoclonic seizures in an otherwise normal infant
age_range: First three years of life
notes: >-
Onset in a child whose development, head size and examination have been
normal. The myoclonic seizure is the only seizure type, and its appearance
in an otherwise well infant is the presentation.
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy, classified among the generalised
idiopathic epilepsies, is characterised by the occurrence of myoclonic
seizures in the first three years of life in otherwise normal infants.
explanation: >-
Gives both the age window and the normal premorbid state that define
this phase.
- phase: Evolution to another epilepsy in a minority
age_range: Later childhood, years after remission
notes: >-
A minority of children go on to develop a different epilepsy after this one
has remitted, usually another idiopathic generalized epilepsy. This
complicates the self-limited framing: what remits may be the infantile
expression of a generalized epilepsy tendency rather than the tendency
itself. A polygraphically documented case followed the syndrome into
childhood absence epilepsy at six years and eight months, which the authors
read as evidence of a shared neurobiological and genetic link between
age-related epileptic phenotypes.
evidence:
- reference: PMID:21752671
reference_title: >-
Benign myoclonic epilepsy in infancy followed by childhood absence
epilepsy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Recently, it has been shown that a few patients with BMEI later had
other epilepsy types mainly IGE but never childhood absence epilepsy
(CAE).
explanation: >-
Establishes that evolution to another epilepsy happens in a minority
and that it is usually another idiopathic generalized epilepsy. Note
that the same sentence asserts absence epilepsy had never been seen,
which is precisely what the case reported in this paper overturned.
- reference: PMID:21752671
reference_title: >-
Benign myoclonic epilepsy in infancy followed by childhood absence
epilepsy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This finding suggests a common neurobiological and genetic link between
different age-related epileptic phenotypes.
explanation: >-
The authors' mechanistic reading of the evolution, which is what makes
this a pathophysiologically interesting phase rather than an incidental
outcome statistic.
- phase: Seizure remission, with development still to be watched
age_range: Childhood, after several years of follow-up
notes: >-
Seizures remit and long-term seizure freedom is the expected outcome, but
the developmental trajectory is not settled at the same time. The literature
is explicit that follow-up should continue for years after diagnosis rather
than ending when the seizures stop, which is an unusual recommendation for a
self-limited epilepsy and follows directly from the cognitive findings.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinicians should distinguish the syndrome of reflex myoclonic epilepsy
in infancy from benign myoclonic epilepsy of infancy and all patients
should continue developmental follow up for several years after
diagnosis.
explanation: >-
States the recommendation for prolonged developmental follow-up, which
is what this phase is about.
treatments:
- name: Sodium Valproate
description: >-
The most effective medication for the myoclonic seizures of this syndrome,
and the drug against which the good seizure prognosis is reported. Its
effect on the developmental outcome is unknown, and given that valproate
has its own neurodevelopmental considerations in young children, that gap
is not merely academic.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: valproic acid
term:
id: CHEBI:39867
label: valproic acid
target_mechanisms:
- target: Generalized Epileptiform Discharge Time-Locked to the Jerk
treatment_effect: INHIBITS
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Prognosis in respect of long term seizure freedom is good with sodium
valproate being the most effective medication.
explanation: >-
Names sodium valproate as the most effective medication and ties it to
the favourable seizure prognosis.
- name: Prolonged Developmental Follow-Up
description: >-
Not a treatment of the seizures but of the actual morbidity of the
syndrome. Because a third of children have cognitive difficulty that is not
apparent when the seizures stop, structured developmental surveillance for
years after diagnosis is what converts an early diagnosis into a useful
one. Recording it as a treatment rather than as advice is deliberate: it is
the intervention that acts on the outcome this syndrome actually threatens.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
target_mechanisms:
- target: Persisting Cognitive and Behavioural Difficulty in a Minority
treatment_effect: MODULATES
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinicians should distinguish the syndrome of reflex myoclonic epilepsy
in infancy from benign myoclonic epilepsy of infancy and all patients
should continue developmental follow up for several years after
diagnosis.
explanation: >-
A direct recommendation for prolonged developmental follow-up in all
patients, which is what this record asserts.
diagnosis:
- name: Video-Electroencephalography with Myoclonus Time-Locking
description: >-
The diagnostic investigation. What is sought is not merely an abnormal
recording but the demonstration that the jerk and the discharge are the
same event, which is what separates this syndrome from the non-epileptic
myoclonias of infancy. Where a reflex presentation is suspected, the
recording includes controlled tactile and acoustic stimulation.
diagnosis_term:
preferred_term: Electroencephalography
term:
id: NCIT:C38054
label: Electroencephalography
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We reviewed all published articles and case reports on RMEI in order to
clarify clinical and electroencephalographic findings, with particular
attention to outcome and treatment.
explanation: >-
Establishes that electroencephalographic findings are central to
delineating the syndrome.
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This rare clinical entity is often under-described and under-diagnosed,
and for this reason should be brought to the attention of paediatricians
in order to avoid extensive investigations and reassure parents of the
lack of long-term complications.
explanation: >-
States the practical purpose of making the diagnosis: recognizing the
reflex entity avoids an unnecessary investigative cascade.
differential_diagnoses:
- name: Dravet Syndrome
disease_term:
preferred_term: Dravet syndrome
term:
id: MONDO:0100135
label: Dravet syndrome
description: >-
The differential that matters most, because both begin in infancy with
seizures in a previously normal child and both involve myoclonus, but the
trajectories diverge completely. Getting this wrong in either direction has
consequences: sodium channel blockers worsen Dravet, and a family told
their child has a self-limited epilepsy when they do not has been badly
misinformed.
distinguishing_features:
- Onset in Dravet is typically with prolonged, often hemiclonic, fever-provoked seizures rather than with brief myoclonic jerks.
- Multiple seizure types appear over time in Dravet; the myoclonic seizure is the only type in this syndrome.
- Development arrests or regresses in the second year in Dravet rather than remaining normal.
- SCN1A mutation is found in the majority of Dravet and is not a feature of this syndrome.
evidence:
- reference: PMID:35503712
reference_title: >-
ILAE classification and definition of epilepsy syndromes with onset in
neonates and infants: Position statement by the ILAE Task Force on
Nosology and Definitions.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Syndromes are separated into self-limited syndromes, where there is
likely to be spontaneous remission and developmental and epileptic
encephalopathies, diseases where there is developmental impairment
related to both the underlying etiology independent of epileptiform
activity and the epileptic encephalopathy.
explanation: >-
Establishes the categorical separation these two syndromes fall on
either side of, which is the axis the differential turns on.
- name: Infantile Epileptic Spasms Syndrome
disease_term:
preferred_term: infantile spasms
term:
id: MONDO:0018097
label: infantile spasms
description: >-
The other clustering infantile seizure that gets confused with myoclonic
jerks. Spasms are slower and more sustained than a myoclonic jerk, come in
long runs particularly on waking, and carry a developmental prognosis that
is the opposite of this syndrome's.
distinguishing_features:
- The spasm is a sustained tonic contraction over one to two seconds rather than a sub-second jerk.
- Spasms cluster in long series, characteristically on waking.
- Hypsarrhythmia on the interictal recording rather than a normal background with brief generalized bursts.
- Developmental arrest or regression accompanies the seizures.
evidence:
- reference: PMID:35503712
reference_title: >-
ILAE classification and definition of epilepsy syndromes with onset in
neonates and infants: Position statement by the ILAE Task Force on
Nosology and Definitions.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Syndromes are separated into self-limited syndromes, where there is
likely to be spontaneous remission and developmental and epileptic
encephalopathies, diseases where there is developmental impairment
related to both the underlying etiology independent of epileptiform
activity and the epileptic encephalopathy.
explanation: >-
Places the two syndromes in the two different categories of the
infantile classification, which is the substance of this differential.
- name: Epilepsy with Myoclonic-Atonic Seizures
disease_term:
preferred_term: epilepsy with myoclonic atonic seizures
term:
id: MONDO:0014633
label: epilepsy with myoclonic atonic seizures
description: >-
Doose syndrome, which also features myoclonus in a previously normal child
but begins later and adds the atonic component that gives it its drop
attacks and its worse prognosis.
distinguishing_features:
- Onset is typically after the third year rather than within it.
- The defining seizure is myoclonic-atonic, with a loss of tone producing a fall, rather than a pure jerk.
- Multiple seizure types including absences and generalized tonic-clonic seizures.
- Outcome is variable and includes drug-resistant epilepsy with cognitive impairment.
evidence:
- reference: PMID:35503712
reference_title: >-
ILAE classification and definition of epilepsy syndromes with onset in
neonates and infants: Position statement by the ILAE Task Force on
Nosology and Definitions.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Syndromes are separated into self-limited syndromes, where there is
likely to be spontaneous remission and developmental and epileptic
encephalopathies, diseases where there is developmental impairment
related to both the underlying etiology independent of epileptiform
activity and the epileptic encephalopathy.
explanation: >-
Gives the categorical axis on which these two syndromes are separated.
Marked PARTIAL because the abstract states the framework rather than
assigning Doose syndrome to a category, and the distinguishing_features
above carry the specific separation.
- name: Benign Non-Epileptic Myoclonus of Infancy
description: >-
Shuddering attacks, benign myoclonus of early infancy, and the other
non-epileptic paroxysmal movements of the first year, which can look
identical to a myoclonic seizure at the bedside and in a parent's video.
The separation is made on the recording, not on the appearance. No MONDO
disease_term is bound because this names a family of non-epileptic
paroxysmal events rather than a single entity.
distinguishing_features:
- No electroencephalographic correlate; the jerk is not time-locked to any discharge.
- Events occur during wakefulness and characteristically stop in sleep.
- No progression to other seizure types and no need for antiseizure medication.
- Resolution is usually within the first two years without treatment.
evidence:
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This rare clinical entity is often under-described and under-diagnosed,
and for this reason should be brought to the attention of paediatricians
in order to avoid extensive investigations and reassure parents of the
lack of long-term complications.
explanation: >-
Supports that recognition of the entity is a diagnostic problem in
infancy and that misrecognition leads to unnecessary investigation.
Marked PARTIAL because the source addresses under-diagnosis of the
epilepsy rather than enumerating the non-epileptic mimics.
discussions:
- discussion_id: mei_benign_label_and_cognitive_outcome
kind: CONTROVERSY
status: UNDER_DISCUSSION
prompt: >-
If about a third of children have lasting cognitive difficulty, what
produces it, and is it the seizures, the substrate that generated them, or
the treatment used to stop them?
attaches_to:
- "pathophysiology#Persisting Cognitive and Behavioural Difficulty in a Minority"
rationale: >-
For forty years this syndrome was called benign, and the seizure data
support that: they respond to valproate and they stop. The developmental
data do not. Roughly a third of children with long-term follow-up have
cognitive problems, in children whose development was normal before onset
and whose seizures remitted. The 2022 ILAE nosology removed benign from the
syndrome names generally, and here the removal has content rather than
being a matter of tone. What is not settled is the mechanism. Three
explanations are available and they are not mutually exclusive. The
seizures or the interictal discharges may themselves interfere with
development during a sensitive window, in which case earlier and more
complete seizure control should improve outcome. The cognitive difficulty
may be a second expression of whatever substrate produces the seizures, in
which case controlling seizures will not change it and the outcome is set
before treatment begins. Or the treatment may contribute, which is not an
idle worry given that the most effective drug in this syndrome is valproate
and that valproate has recognized neurodevelopmental considerations in very
young children. These make sharply different predictions and none has been
tested against the others, largely because the syndrome is rare enough that
the whole literature is a hundred-odd cases.
proposed_experiments:
- experiment_id: mei_seizure_burden_versus_outcome
name: Seizure and discharge burden against developmental outcome
description: >-
A prospective multicentre cohort with quantified seizure counts and
interictal discharge burden from serial recordings during the active
phase, and standardized developmental assessment at school age, testing
whether burden during infancy predicts outcome once age at onset and
treatment are accounted for.
decision_criterion: >-
A dose-response relationship between seizure or discharge burden and
later cognitive score would support the seizures interfering with
development. Absence of any relationship would point to a shared
substrate or to treatment.
- experiment_id: mei_valproate_versus_alternative_outcome
name: Developmental outcome by treatment received
description: >-
Comparison of developmental outcome between children treated with
valproate and those treated with an alternative agent or untreated,
drawn from a multicentre registry, with adjustment for seizure burden
and age at onset. Randomization is not realistic at this syndrome's
case numbers, so this is explicitly an observational design with the
confounding-by-indication limitation stated.
decision_criterion: >-
Worse outcome in valproate-treated children after adjustment for
seizure burden would raise treatment contribution as a real
possibility. Equivalent outcomes across treatments would largely
exclude it.
- experiment_id: mei_premorbid_and_familial_markers
name: Premorbid and familial markers of the cognitive subgroup
description: >-
Testing whether the third of children with cognitive difficulty are
identifiable before or at onset by family history, subtle premorbid
developmental measures, or genetic findings, rather than only in
retrospect.
decision_criterion: >-
Identification of a premorbid or familial marker would support the
shared-substrate explanation and would make the subgroup prospectively
identifiable. No such marker would leave the seizure and treatment
explanations in play.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
However, the cognitive outcome is much less certain with cognitive
problems present in one-third of children who have long term follow up.
explanation: >-
The finding the controversy is about, and the contrast with the
favourable seizure prognosis reported in the preceding sentence of the
same abstract.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Prognosis in respect of long term seizure freedom is good with sodium
valproate being the most effective medication.
explanation: >-
Establishes both halves of the tension: the seizures do well, and the
drug they do well on is the one whose developmental profile the third
explanation implicates.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The term benign may be appropriately used to describe the myoclonic
seizures but must be used cautiously when counselling families about
cognitive outcome.
explanation: >-
The authors' own resolution, which separates the two prognoses rather
than reconciling them, and which the 2022 renaming subsequently
endorsed.
- discussion_id: mei_reflex_variant_separate_syndrome
kind: CONTROVERSY
status: UNDER_DISCUSSION
prompt: >-
Is reflex myoclonic epilepsy in infancy a variant of this syndrome or a
separate entity, and does the uniformly normal cognitive outcome of the
reflex group settle it?
attaches_to:
- "pathophysiology#Reflex Sensitivity to Tactile and Acoustic Stimuli in a Subset"
rationale: >-
Twenty-three of the just-over-hundred reported cases had seizures elicited
by sudden touch or noise rather than occurring spontaneously, and their
inclusion in the syndrome is described in the literature as debatable in
those words. Two things pull in opposite directions. Against separation:
the seizure type is the same myoclonic jerk, the age window is the same,
the electroencephalographic picture is described as the same, and dividing
a hundred-case literature into two fifty-case literatures makes both harder
to study. For separation: the cognitive outcome differs, and it differs in
exactly the place where this syndrome's real morbidity lives. Every
reported reflex case has been developmentally normal, against a third of
the syndrome as a whole having cognitive difficulty. If that difference is
real rather than an artefact of small numbers and shorter follow-up, the
reflex group is not a variant but a genuinely better-prognosis entity, and
one review explicitly recommends that clinicians distinguish them. The
curation consequence is concrete: this entry currently models the reflex
presentation as a node within the syndrome, and if the separation is
confirmed it should become its own entry.
proposed_experiments:
- experiment_id: mei_reflex_matched_followup
name: Matched-duration follow-up of reflex and spontaneous groups
description: >-
Pooled reanalysis of reported cases with developmental outcome censored
at equal follow-up duration in both groups, testing whether the reflex
group's uniformly normal outcome survives matching, or whether it
reflects shorter follow-up in a group that presents more benignly and
is discharged earlier.
decision_criterion: >-
A persisting outcome difference at matched follow-up supports genuine
separation. Convergence of outcomes once follow-up is equalized would
indicate the difference was an ascertainment artefact.
- experiment_id: mei_reflex_electrophysiological_signature
name: Electrophysiological comparison of reflex and spontaneous jerks
description: >-
Direct comparison of discharge morphology, the latency from stimulus to
jerk in the reflex group, and any somatosensory or auditory evoked
response abnormality, against age-matched children with the spontaneous
form.
decision_criterion: >-
A reproducible electrophysiological difference, particularly an evoked
response abnormality present only in the reflex group, would support
two mechanisms. Indistinguishable physiology would support one syndrome
with a triggered presentation.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This includes 23 infants with reflex myoclonic epilepsy whose inclusion
in the wider syndrome remains debatable.
explanation: >-
States the dispute directly, and gives the size of the disputed group
against the whole reported literature.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The cognitive outcome in reflex myoclonic epilepsy of infancy is normal
in all reported cases.
explanation: >-
The main empirical argument for separation, and the reason the question
is not merely nosological.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinicians should distinguish the syndrome of reflex myoclonic epilepsy
in infancy from benign myoclonic epilepsy of infancy and all patients
should continue developmental follow up for several years after
diagnosis.
explanation: >-
An explicit recommendation to distinguish the two, which is the
strongest statement in the cited literature in favour of separation.
- reference: PMID:23770486
reference_title: "Reflex myoclonic epilepsy in infancy: a critical review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
RMEI appears to be a benign variant of idiopathic myoclonic epilepsy in
infancy with specific features that occur in neurologically and
developmentally normal children.
explanation: >-
The opposing position, from a review devoted to the reflex entity: it
calls RMEI a variant rather than a separate syndrome, while still
crediting it with specific features. Marked PARTIAL because it supports
the variant reading rather than the separation this discussion is
weighing.
- discussion_id: mei_genetic_basis_unknown
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
What are the genetic mechanisms underlying myoclonic epilepsy in infancy,
and is the syndrome's clinical heterogeneity the surface of genuine genetic
heterogeneity?
attaches_to:
- "pathophysiology#Age-Restricted Generalized Cortical Hyperexcitability of Infancy"
rationale: >-
This entry carries no genetic section and the omission is deliberate. The
literature reads the syndrome as genetic on the strength of its clinical
shape rather than on mapping evidence, and it goes a step further, taking
the heterogeneity of the presentation as a hint that several different
genetic mechanisms converge on the same picture. That is a testable claim
and nobody has tested it. The obstacle is arithmetic: just over a hundred
cases in four decades means no single centre has a cohort, and the reflex
dispute would split even that. The consequence for this knowledge base is
that borrowing candidate genes from adjacent infantile myoclonic epilepsies
would be inventing content, and the gap is recorded here instead. It also
connects to the other two discussions: if the cognitive subgroup and the
reflex subgroup have distinct genetic bases, both of those disputes resolve
at once.
proposed_experiments:
- experiment_id: mei_multicentre_sequencing
name: Multicentre sequencing cohort with phenotype stratification
description: >-
Trio exome or genome sequencing of an internationally aggregated cohort
recruited on current ILAE criteria, stratified at entry by reflex versus
spontaneous presentation and followed for developmental outcome, so
that any genetic findings can be tested against both open sub-questions
rather than only against the diagnosis.
decision_criterion: >-
Recurrent variants in one or more genes would establish a genetic
basis; finding different genes segregating with the reflex and
spontaneous groups, or with the cognitive outcome, would resolve those
disputes directly. A null result at adequate power would support
polygenic susceptibility.
- experiment_id: mei_family_aggregation_study
name: Family aggregation and febrile seizure history
description: >-
Systematic ascertainment of family history of epilepsy and febrile
seizures in a multicentre cohort against matched controls, to quantify
familial aggregation before any molecular work, which is feasible at
this syndrome's numbers where sequencing cohorts are not.
decision_criterion: >-
Significant familial aggregation would justify the sequencing
investment and would constrain the plausible architecture. Aggregation
no greater than background would weaken the genetic presumption the
field currently holds.
evidence:
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The clinical heterogeneity within this syndrome suggests that there may
be a variety of genetic mechanisms that underlie the presentation.
explanation: >-
The hypothesis this gap is about, stated as a suggestion drawn from
clinical observation rather than from any molecular finding.
- reference: PMID:16904290
reference_title: >-
Developmental outcome in benign myoclonic epilepsy in infancy and
reflex myoclonic epilepsy in infancy: a literature review and six new
cases.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Benign myoclonic epilepsy in infancy is a rare syndrome with just over
100 cases reported since the first syndromic description by Dravet and
Bureau
explanation: >-
Quantifies the obstacle: a four-decade literature of about a hundred
cases is why no adequately powered genetic study exists, which is the
reason the proposed experiments are multicentre and aggregated.
Myoclonic epilepsy in infancy (MEI) is a rare, usually self-limited generalized epilepsy syndrome beginning in an otherwise normally developing infant. Its defining events are brief generalized myoclonic seizures, particularly of the head and upper limbs, occurring repeatedly in wakefulness and sleep. The most authoritative current definition is the International League Against Epilepsy (ILAE) 2022 position statement on neonatal- and infant-onset epilepsy syndromes, published May 2022 (DOI: https://doi.org/10.1111/epi.17239). (zuberi2022ilaeclassificationand pages 12-14)
A critical terminology warning is required: MEI is not Dravet syndrome, whose historical name was “severe myoclonic epilepsy in infancy” (SMEI). Dravet syndrome is a developmental and epileptic encephalopathy, usually associated with SCN1A, prolonged febrile or afebrile hemiclonic/generalized convulsive seizures, pharmacoresistance, and developmental impairment. MEI must also not be merged with familial infantile myoclonic epilepsy, a separately indexed genetic entity associated in disease databases with genes including TBC1D24, SCN8A, CPLX1, and KIF5A. Open Targets gives classic MEI as MONDO_0100566 but reports no established disease–target association for that entity. (OpenTargets Search: myoclonic epilepsy in infancy, zuberi2022ilaeclassificationand pages 12-14)
| Domain | Evidence summary for Myoclonic Epilepsy in Infancy (MEI) | Suggested ontology terms | Key citation |
|---|---|---|---|
| Classification / scope | Rare infant-onset epilepsy syndrome recognized by ILAE 2022; a self-limited infantile generalized epilepsy syndrome. Do not conflate with Dravet syndrome (formerly severe myoclonic epilepsy in infancy; developmental/epileptic encephalopathy, usually SCN1A-related) or with familial infantile myoclonic epilepsy (distinct familial/genetic entity). MONDO: MONDO_0100566. | MONDO: MONDO_0100566; NCIT: Epilepsy syndrome-related concept; HPO: HP:0002123 (Generalized myoclonic seizure) | (OpenTargets Search: myoclonic epilepsy in infancy, zuberi2022ilaeclassificationand pages 12-14) |
| Epidemiology | Rare: <0.8% of children with epilepsy in specialty settings; 1.1% of all epilepsy with onset before 36 months in a population-based cohort. Male predominance about 2:1. | PATO/clinical descriptor: male predominance | (zuberi2022ilaeclassificationand pages 12-14) |
| Onset | Usual onset 4 months to 3 years, with peak 6–18 months. Onset at ≤4 months or >3 years is a warning/exclusionary feature for classic MEI. | HPO: HP:0011463 (Childhood onset), HP:0003593 (Infantile onset) | (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16, bayat2021epilepsysyndromesin pages 6-8) |
| Core seizures | Mandatory phenotype: frequent myoclonic seizures involving head and upper limbs/upper arms, occurring multiple times daily, during wakefulness and sleep. At syndrome onset, other seizure types should be absent. | HPO: HP:0002123 (Generalized myoclonic seizure) | (zuberi2022ilaeclassificationand pages 12-14, bayat2021epilepsysyndromesin pages 6-8) |
| Triggers / reflex features | About one-third have reflex-provoked seizures triggered by sudden noise, touch, or startle; intermittent photic stimulation may also precipitate events in some reports. | HPO: HP:0025258 (Startle-induced seizure) or related reflex-seizure descriptor | (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16) |
| EEG | Background typically normal while awake. Interictal EEG shows generalized spike-wave or polyspike-wave discharges, often around ~3 Hz, more evident in early sleep. If sleep EEG lacks generalized spike-wave, ictal EEG is strongly recommended because some myoclonic events may lack a clear EEG correlate. | HPO: HP:0010848 (Abnormality of EEG); EDAM/EEG descriptor: generalized spike-wave discharge | (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16) |
| MRI / imaging | No causal lesion expected; nonlesional brain MRI supports diagnosis. Structural lesion argues against classic MEI. | UBERON: brain; RadLex/SNOMED descriptor: normal brain MRI | (zuberi2022ilaeclassificationand pages 14-16) |
| Development / exam | Development before seizure onset is typically normal and neurological examination is normal. Long-term development is normal in 63–85%; some later show mild intellectual disability, learning disorder, or attention problems; rarely moderate-severe ID occurs. | HPO: HP:0001263 (Global developmental delay) when present; HP:0001249 (Intellectual disability); HP:0007018 (Attention deficit) | (zuberi2022ilaeclassificationand pages 12-14) |
| Genetics | Family history of epilepsy or febrile seizures in about 10%. No causal genes are established for classic MEI in the ILAE 2022 definition. Reported gene-associated “myoclonic epilepsy of infancy” cases should be interpreted cautiously as possible phenocopies/etiology-specific epilepsies, not proof of monogenic classic MEI. | No validated causal gene annotation for classic MEI; avoid asserting SCN1A/SLC2A1/YWHAG as established MEI causes | (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16, bayat2021epilepsysyndromesin pages 6-8) |
| Course / prognosis | Favorable seizure course: myoclonic seizures remit in nearly all cases within 6 months to 5 years; most children can discontinue antiseizure medication. About 10% later develop another epilepsy, most commonly juvenile myoclonic epilepsy. | HPO: HP:0011458 (EEG with generalized spike-wave); clinical course descriptor: self-limited/remitting | (zuberi2022ilaeclassificationand pages 12-14, bayat2021epilepsysyndromesin pages 6-8) |
| Diagnosis / differential | Diagnosis is syndrome-based using age at onset, seizure semiology, normal development, normal exam, normal/nonlesional MRI, and generalized spike-/polyspike-wave on EEG. Exclusionary seizure types at onset include absence, atonic, epileptic spasms, focal seizures, generalized tonic-clonic, or clonic seizures. Key differentials: benign myoclonus of infancy, hyperekplexia, hypnic jerks, Dravet syndrome, and epilepsy with myoclonic-atonic seizures. | HPO: HP:0002376 (Febrile seizures) when present; SNOMED/NCIT differential diagnosis descriptors | (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16) |
| Treatment / evidence gaps | No MEI-specific modern trials were identified. Standard practice in reviews has favored antiseizure medication with later withdrawal after remission; ILAE evidence notes that most children discontinue treatment after remission, but robust comparative data are lacking. Evidence gaps: no established biomarker, no confirmed molecular pathway, no precision therapy, no prevention strategy, no disease-specific clinical trials located for classic MEI. | NCIT: Anticonvulsant therapy; evidence-gap flag for biomarker/genetic/advanced-therapy fields | (zuberi2022ilaeclassificationand pages 12-14, bayat2021epilepsysyndromesin pages 6-8) |
Table: This table compiles ontology-ready, knowledge-base-focused evidence for classic Myoclonic Epilepsy in Infancy, centered on the 2022 ILAE definition and supporting review data. It highlights key diagnostic and prognostic facts while explicitly separating MEI from Dravet syndrome and familial infantile myoclonic epilepsy.
MEI is an electroclinical syndrome—an age-dependent cluster of seizure and EEG features—rather than a disease currently defined by a single molecular lesion. The ILAE places it among epilepsy syndromes beginning in neonates and infants and describes a self-limited course in most affected children. Data are aggregated from syndrome-level clinical cohorts, specialty-center series, population-based epilepsy cohorts, and expert consensus; they are not individual-patient EHR data in this report. (zuberi2022ilaeclassificationand pages 12-14)
Preferred name: Myoclonic epilepsy in infancy.
Common synonyms: myoclonic epilepsy of infancy; benign myoclonic epilepsy in infancy; benign myoclonic epilepsy of infancy. “Benign” is now generally avoided because 15–37% of reported patients do not have completely normal long-term neurodevelopment and approximately 10% later develop another epilepsy. The reflex-predominant phenotype may be called reflex myoclonic epilepsy in infancy. (zuberi2022ilaeclassificationand pages 14-16, zuberi2022ilaeclassificationand pages 12-14)
Identifiers:
The cause of classic MEI remains unresolved. Approximately 10% have a family history of epilepsy or febrile seizures, supporting genetic susceptibility, but the ILAE review states that no causal gene has been identified for the classic syndrome. Therefore, SCN1A, SLC2A1, YWHAG, TBC1D24, or other epilepsy genes should not be annotated as established MEI causes without evidence that the individual satisfies classic ILAE MEI criteria and that competing etiology-specific syndromes have been excluded. (zuberi2022ilaeclassificationand pages 14-16, bayat2021epilepsysyndromesin pages 6-8)
No reproducible susceptibility locus, modifier gene, protective allele, epigenetic signature, or chromosomal abnormality is established. The relevant inheritance model is consequently unknown/complex, not proven autosomal dominant or recessive. Penetrance, carrier frequency, anticipation, founder effects, and germline-mosaicism rates cannot presently be assigned.
No toxin, pollutant, occupation, diet, infection, vaccination, smoking exposure, or other lifestyle factor is established as a cause. Sudden sound, touch, startle, and occasionally intermittent photic stimulation can precipitate individual seizures but are reflex triggers, not causes of the underlying epilepsy. Febrile seizures occur in up to one-third and may precede or follow the myoclonic seizures, but fever should not be interpreted as a demonstrated etiologic exposure. (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16)
No validated genetic or environmental protective factor, formal gene–environment interaction, or primary prevention strategy is known.
The mandatory clinical phenotype is frequent brief myoclonic seizures involving the head and upper arms/upper limbs, commonly producing head nods, shoulder or arm jerks, or brief loss of hand control. Events occur several or multiple times daily, in both wakefulness and sleep. Consciousness is usually preserved or only too briefly affected to assess. Approximately one-third of patients have reflex events induced by noise, touch, or startle. (zuberi2022ilaeclassificationand pages 12-14, bayat2021epilepsysyndromesin pages 6-8)
Suggested terms include generalized myoclonic seizure (HPO HP:0002123), infantile onset (HP:0003593), febrile seizures (HP:0002376) when present, and an appropriate reflex/startle-induced seizure term when supported by the record. Because ontology labels evolve, identifiers should be checked against the production HPO release before ingestion.
The awake background is typically normal. Interictal EEG demonstrates generalized spike-wave or polyspike-wave discharges, commonly more evident in early sleep. The electroclinical discharge is often described at approximately 3 Hz. A sleep recording is therefore important. If interictal sleep EEG does not show generalized spike-wave, ictal video-EEG is strongly recommended to distinguish epileptic myoclonus from nonepileptic infantile myoclonus, hyperekplexia, or physiological hypnic jerks. (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16)
Suggested annotations are abnormal EEG (HP:0010848) and generalized spike-wave/polyspike-wave descriptors. The ictal event and EEG correlate should be represented separately where the data model permits.
Development before seizure onset and neurological examination are ordinarily normal. Long-term development is reported as normal in 63–85%. A minority develops mild intellectual disability, learning difficulties, or attention problems; moderate-to-severe intellectual disability is rare and is not necessarily proportional to seizure frequency. Relevant conditional terms include intellectual disability (HP:0001249), global developmental delay (HP:0001263), learning disability, and attention deficit. (zuberi2022ilaeclassificationand pages 12-14)
Febrile seizures occur in up to one-third. At onset, absence, atonic, focal, clonic, generalized tonic-clonic seizures, or epileptic spasms are exclusionary for classic MEI. Falls, persistent focal deficits, dysmorphism, movement disorder, regression, and systemic laboratory abnormalities are not defining features and should prompt reassessment. (zuberi2022ilaeclassificationand pages 12-14)
No MEI-specific EQ-5D, SF-36, PROMIS, or validated caregiver quality-of-life statistics were identified. During the active phase, multiple daily jerks can impair feeding, object handling, sleep, safety, and caregiver confidence. Later learning or attention problems may affect school functioning even after seizure remission, which helps explain why “benign” is an imperfect label. These functional effects are clinically plausible but are not quantified in the available syndrome literature.
There is presently no validated causal gene, recurrent pathogenic variant, HGNC-defined gene set, allele frequency, or established loss-/gain-of-function mechanism for classic MEI. Consequently, no variant should be classified as “pathogenic for MEI” solely because it occurs in a person with infantile myoclonus. Molecular findings must be interpreted under ACMG/AMP criteria and against the gene-specific phenotype.
The database distinction is especially important: Open Targets links familial infantile myoclonic epilepsy (MONDO:0011506) to TBC1D24, SCN8A, CPLX1, and KIF5A, while its classic MEI record has no associated targets. These associations cannot be transferred across disease records. (OpenTargets Search: myoclonic epilepsy in infancy)
No established modifier gene, DNA-methylation signature, histone abnormality, pathogenic copy-number change, or recurrent chromosomal rearrangement has been demonstrated. Reports of gene-positive MEI-like phenotypes should be represented as gene-associated epilepsy with an MEI-like presentation pending replication and nosological validation.
No causal environmental exposure or infectious agent has been identified. Sound, tactile stimulation, startle, and occasionally light stimulation activate susceptible seizure networks in reflex MEI. Practical stimulus management may reduce provoked events, but excessive avoidance can adversely affect normal infant development and is not disease-modifying. There is no evidence that diet, exercise, alcohol, tobacco, pollution, radiation, or occupational exposure has a disease-specific role in infants with classic MEI. (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16)
The best-supported causal chain is electroclinical rather than molecular:
Steps 1 and 5 remain hypotheses; no MEI-specific channel, receptor, transmitter, inflammatory, metabolic, or mTOR/PI3K-AKT pathway defect is established. The normal neurological examination, normal awake background, and nonlesional MRI support functional network dysregulation rather than progressive tissue destruction. (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16)
Suggested broad GO annotations, to be used as mechanistic hypotheses rather than demonstrated disease mechanisms, include regulation of membrane potential (GO:0042391), synaptic signaling (GO:0099536), regulation of neuronal action potential, and synchronization of neuronal activity. Candidate cell types include excitatory and inhibitory neurons—glutamatergic neuron (CL:0000679) and GABAergic neuron (CL:0000617)—but no MEI-specific cellular pathology has been shown.
No disease-specific transcriptomic, single-cell, spatial-transcriptomic, proteomic, metabolomic, lipidomic, CRISPR-screen, or multi-omics result was identified. There is likewise no established immune activation, oxidative injury, neurodegeneration, apoptosis, autophagy defect, enzyme deficiency, or tissue-damage mechanism.
The clinically affected organ is the central nervous system, particularly bilateral brain networks generating generalized epileptiform activity and motor output. Suggested anatomical annotations are brain (UBERON:0000955), cerebral cortex (UBERON:0000956), and possibly thalamus/generalized thalamocortical network as a systems-level inference. There is no consistent focal lesion, lateralization, or secondary organ involvement. (zuberi2022ilaeclassificationand pages 14-16)
At subcellular level, neuronal plasma membrane, axon, synapse, and postsynaptic membrane are biologically plausible compartments, but none is specifically proven. A normal/nonlesional MRI is expected; a causal structural lesion argues against classic MEI.
Onset is usually 4 months to 3 years, peaking at 6–18 months. Onset at or before 4 months or after 3 years is an alert against the classic diagnosis. The beginning may be abrupt from the caregiver’s perspective, but the course is episodic, with multiple daily seizures during the active phase. (zuberi2022ilaeclassificationand pages 12-14, zuberi2022ilaeclassificationand pages 14-16)
Myoclonic seizures remit in nearly all patients within 6 months to 5 years after onset. Most ultimately discontinue antiseizure medication. Approximately 10% develop another epilepsy in later childhood or adolescence, most often juvenile myoclonic epilepsy. Developmental surveillance should therefore continue after seizure remission. (bayat2021epilepsysyndromesin pages 6-8, zuberi2022ilaeclassificationand pages 12-14)
There are no validated early/intermediate/advanced stages. The useful clinical phases are active infantile myoclonus, seizure remission, medication withdrawal where appropriate, and longer-term monitoring for learning/attention difficulties or later generalized epilepsy.
MEI constitutes <0.8% of children with epilepsy seen in specialty centers and approximately 1.1% of epilepsies beginning before 36 months in the population-based evidence summarized by ILAE. Male predominance is approximately 2:1. These figures do not provide robust prevalence per 100,000 or annual incidence estimates, and geographic or ancestry-specific differences have not been established. (zuberi2022ilaeclassificationand pages 12-14)
Family history of epilepsy or febrile seizures occurs in about 10%, but Mendelian inheritance, penetrance, expressivity, carrier frequency, anticipation, founder effects, and consanguinity effects remain undefined. (zuberi2022ilaeclassificationand pages 14-16, bayat2021epilepsysyndromesin pages 6-8)
Diagnosis rests on the age-dependent electroclinical pattern:
Video-EEG including sleep is the key test. Ictal recording is particularly valuable if habitual jerks have no clear interictal correlate. Brain MRI is expected to be nonlesional; MRI is appropriate when there are focal findings, atypical development, abnormal examination, or an atypical EEG. Routine blood chemistry, metabolic studies, CSF, biopsy, PET, EMG, ECG, or other biomarkers are not diagnostic for classic MEI and should be guided by atypical features.
Genetic testing is not required to confirm a textbook MEI phenotype because no causal gene is established. Nevertheless, an infantile epilepsy panel or exome/genome sequencing is reasonable when there is developmental delay/regression, dysmorphism, drug resistance, focal or multiple seizure types, abnormal MRI, very early onset, a strong family history, or failure to meet ILAE criteria. Such testing primarily detects alternative etiologies, not classic MEI. Broad early-onset epilepsy literature supports panels, exomes, or genomes because they can identify actionable phenocopies, but this evidence is not an MEI-specific diagnostic-yield estimate. (bayat2021epilepsysyndromesin pages 6-8)
CMA is appropriate when developmental or congenital abnormalities suggest a copy-number disorder. Karyotype, FISH, mitochondrial DNA, RNA sequencing, and repeat-expansion testing are not routine MEI tests unless another phenotype indicates them.
There is no population or newborn screening program for MEI. Screening asymptomatic relatives is not supported because no validated causal gene exists.
Seizure prognosis is excellent: nearly all patients remit over 6 months to 5 years, and most eventually stop medication. Long-term neurodevelopment is normal in 63–85%, but mild intellectual, learning, or attention problems occur in a clinically important minority. Approximately 10% later develop another epilepsy. (zuberi2022ilaeclassificationand pages 12-14)
No MEI-specific 5- or 10-year survival rate, excess mortality rate, SUDEP estimate, or reduction in life expectancy was identified. Current evidence does not characterize classic MEI as a progressive or lethal disorder. Prognostically adverse signals include atypical onset age, abnormal development or examination, additional seizure types, focal EEG/MRI abnormalities, persistent drug resistance, or failure of expected remission; these features should trigger diagnostic reconsideration rather than automatically being labeled severe MEI.
No validated molecular prognostic biomarker or disease-specific quality-of-life instrument exists.
Evidence consists mainly of observational series and expert practice rather than modern randomized MEI trials. A broad-spectrum antiseizure medication is used when seizures are frequent, disruptive, or diagnostically secure. Historical and review-based practice most commonly favors valproate as first-line monotherapy for generalized myoclonus; levetiracetam, clonazepam, or topiramate may be considered when valproate is unsuitable or ineffective. These alternatives have substantially weaker MEI-specific evidence. The ILAE evidence establishes that most patients ultimately discontinue therapy after remission but does not provide comparative response rates. (zuberi2022ilaeclassificationand pages 12-14)
Suggested NCIT-level intervention concepts are anticonvulsant therapy, valproic acid, levetiracetam, clonazepam, and topiramate; exact NCIT identifiers should be verified against the current release. Medication selection and withdrawal should be supervised by a pediatric neurologist. Valproate requires age-appropriate counseling and monitoring for hepatic toxicity, pancreatitis, thrombocytopenia, hyperammonemia, weight/metabolic effects, and future reproductive risk. Benzodiazepines may cause sedation or tolerance; levetiracetam may cause behavioral adverse effects; topiramate can impair appetite, cognition, acid-base balance, and renal-stone risk.
A practical algorithm is: confirm epileptic myoclonus with video-EEG including sleep; treat frequent events with a broad-spectrum ASM; reassess seizure and developmental response; investigate phenocopies if resistant or atypical; and consider gradual withdrawal after sustained electroclinical remission. There is no evidence for epilepsy surgery because MEI is generalized and nonlesional. Ketogenic diet, vagus-nerve stimulation, immunotherapy, or other interventions are not routine for classic MEI; needing them should prompt reconsideration of the diagnosis.
No MEI-specific gene therapy, ASO, siRNA, mRNA, cell therapy, CRISPR therapy, targeted small molecule, immunotherapy, or interventional clinical trial was identified. Trials retrieved for SCN1A-Dravet syndrome—including zorevunersen/STK-001 studies—are not MEI trials and should not populate the MEI treatment record.
Supportive care includes seizure first-aid education, individualized safety advice, developmental and school surveillance, and speech, occupational, behavioral, or educational intervention when deficits are detected.
Primary prevention is unavailable because the cause is unknown. Vaccination is not a disease-specific preventive intervention and routine immunization should follow standard pediatric recommendations. Avoidance of known abrupt sensory triggers may reduce individual reflex seizures but does not prevent MEI and should be balanced against normal development.
Secondary prevention consists of prompt recognition, video-EEG confirmation, treatment when warranted, and avoidance of diagnostic delay. Tertiary prevention includes injury precautions, fever/seizure plans, monitoring treatment toxicity, developmental surveillance, and follow-up into adolescence for later generalized epilepsy. There is no validated carrier, prenatal, preimplantation, newborn, or cascade-screening program for classic MEI. Genetic counseling should emphasize uncertain etiology and avoid assigning a Mendelian recurrence risk without a specific molecular diagnosis.
No naturally occurring veterinary disorder was identified as a validated species homolog of classic human MEI. Animal epilepsies involving myoclonus or orthologues such as Scn1a, Scn8a, or Tbc1d24 model other genetic epilepsies and must not automatically be labeled MEI. No zoonotic transmission or cross-species infectious susceptibility applies.
No validated disease-specific mouse, rat, zebrafish, Drosophila, C. elegans, organoid, iPSC, or cellular model of classic MEI was identified, consistent with the absence of a confirmed molecular cause. Generalized spike-wave and reflex-seizure models can test network excitability or antiseizure drugs, but they do not reproduce the complete age, seizure, EEG, remission, and developmental phenotype required for construct and face validity. Gene-specific models are appropriate only for the corresponding etiology-specific epilepsy or phenocopy.
The decisive modern development is the 2022 ILAE standardized syndrome definition, which provides epidemiology, mandatory criteria, alerts, exclusions, EEG expectations, imaging findings, and natural history. Its abstract defines an epilepsy syndrome as an electroclinical cluster and separates self-limited infantile syndromes from developmental and epileptic encephalopathies; this is the appropriate framework for MEI. Publication: May 2022; DOI URL: https://doi.org/10.1111/epi.17239. (zuberi2022ilaeclassificationand pages 12-14)
A 2021 genetics review states that comprehensive panels, exomes, and genomes have increased diagnostic yield in early-onset epilepsies and enabled precision medicine, while specifically noting that causal genes for MEI had not been identified. Its abstract states that “early genetic testing is a cornerstone” of precision strategies in monogenic epilepsies; for MEI, the principal present utility is finding an alternative molecular diagnosis. Publication: July 2021; DOI URL: https://doi.org/10.3390/genes12071051. (bayat2021epilepsysyndromesin pages 6-8)
No 2023–2024 primary study was found that overturns the 2022 ILAE understanding of classic MEI, establishes a causal gene, supplies population prevalence per 100,000, or demonstrates a disease-specific therapy. The most defensible current expert position is therefore conservative: diagnose MEI electroclinically, preserve strict separation from Dravet syndrome and familial infantile myoclonic epilepsy, use genetic testing for atypical presentations/phenocopies, and explicitly mark molecular, omics, prevention, model, and trial fields as unresolved.
References
(zuberi2022ilaeclassificationand pages 12-14): Sameer M. Zuberi, Elaine Wirrell, Elissa Yozawitz, Jo M. Wilmshurst, Nicola Specchio, Kate Riney, Ronit Pressler, Stephane Auvin, Pauline Samia, Edouard Hirsch, Santiago Galicchio, Chahnez Triki, O. Carter Snead, Samuel Wiebe, J. Helen Cross, Paolo Tinuper, Ingrid E. Scheffer, Emilio Perucca, Solomon L. Moshé, and Rima Nabbout. Ilae classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ilae task force on nosology and definitions. Epilepsia, 63:1349-1397, May 2022. URL: https://doi.org/10.1111/epi.17239, doi:10.1111/epi.17239. This article has 1122 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: myoclonic epilepsy in infancy): Open Targets Query (myoclonic epilepsy in infancy, 24 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(zuberi2022ilaeclassificationand pages 14-16): Sameer M. Zuberi, Elaine Wirrell, Elissa Yozawitz, Jo M. Wilmshurst, Nicola Specchio, Kate Riney, Ronit Pressler, Stephane Auvin, Pauline Samia, Edouard Hirsch, Santiago Galicchio, Chahnez Triki, O. Carter Snead, Samuel Wiebe, J. Helen Cross, Paolo Tinuper, Ingrid E. Scheffer, Emilio Perucca, Solomon L. Moshé, and Rima Nabbout. Ilae classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ilae task force on nosology and definitions. Epilepsia, 63:1349-1397, May 2022. URL: https://doi.org/10.1111/epi.17239, doi:10.1111/epi.17239. This article has 1122 citations and is from a domain leading peer-reviewed journal.
(bayat2021epilepsysyndromesin pages 6-8): Allan Bayat, Michael Bayat, Guido Rubboli, and Rikke S. Møller. Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision therapy. Genes, 12:1051, Jul 2021. URL: https://doi.org/10.3390/genes12071051, doi:10.3390/genes12071051. This article has 119 citations.